Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia
-
Niels H. Birkebaek
,
David M. Hougaard
Abstract
Background:
The objective of this study was to compare the analysis of 17-hydroxyprogesterone (17-OHP) by radio-immunoassay (RIA) in serum with analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS) on dried blood spot samples (DBSS) for monitoring therapy in children with congenital adrenal hyperplasia (CAH), and to investigate differences in 17-OHP values during the day.
Methods:
Fourteen children (8 females), median age 4.2 (0.3–16.0) years, were studied. Serum samples and DBSS were drawn before hydrocortisone dosing.
Results:
17-OHP by LC-MS/MS in DBSS were highly correlated to 17-OHP by RIA in serum, r=0.956, p<0.01. A total of 26 three-time-point series were investigated. Using only the afternoon 17-OHP values to determine the hydrocortisone doses would have led to overdosing seven times and underdosing six times.
Conclusions:
Good agreement was demonstrated between 17-OHP determination by RIA in serum and LC-MS/MS on DBSS. Multiple 17-OHP measurements per day are required to ensure sufficient hydrocortisone dose adjustment.
Acknowledgments
The authors wish to thank the specialist nurses Lene S. Poulsen and Lisbeth M. Pedersen for practical coordination of the blood sampling.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report or in the decision to submit the report for publication.
References
1. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95:4133–66.10.1210/jc.2009-2631Suche in Google Scholar
2. Turcu AF, Rege J, Chomic R, Liu J, Nishimoto HK, et al. Profiles of 21-carbon steroids in 21-hydroxylase deficiency. J Clin Endocrinol Metab 2015;100:2283–90.10.1210/jc.2015-1023Suche in Google Scholar
3. New MI, Abrahama M, Gonzaleza B, Dumic M, Razzaghy-Azar M, et al. Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 2013;110:2611–6.10.1073/pnas.1300057110Suche in Google Scholar
4. Kim MS, Ryabets-Lienhard A, Geffner ME. Management of congenital adrenal hyperplasia in childhood. Curr Opin Endocrinol Diabetes Obes 2012;19:483–8.10.1097/MED.0b013e32835a1a1bSuche in Google Scholar
5. Gan EH, Quinton R. Physiological significance of the rhythmic secretion of hypothalamic and pituitary hormones. Prog Brain Res 2010;181:111–26.10.1016/S0079-6123(08)81007-2Suche in Google Scholar
6. Dauber A, Kellogg M, Majzoub JA. Monitoring of therapy in congenital adrenal hyperplasia. Clin Chem 2010;56:1245–51.10.1373/clinchem.2010.146035Suche in Google Scholar PubMed
7. Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, et al. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem 2004;50:621–5.10.1373/clinchem.2003.027193Suche in Google Scholar PubMed
8. Faurschou S, Mouritsen A, Johannsen TH, Hougaard DM, Cohen A, et al. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life. Acta Paediatr 2015;104:e57–62.10.1111/apa.12835Suche in Google Scholar PubMed
9. Higashi T, Suzuki M, Inagaki S, Inagaki S, Min JZ, et al. A specific LC/ESI- MS/MS method for determination of 25-hydroxyvitamin D3 in neonatal dried blood spots containing a potential interfering metabolite, 3-epi-25-hydroxyvitamin D3. J Sep Sci 2011;34:725–32.10.1002/jssc.201000911Suche in Google Scholar PubMed
10. Hindmarsh PC, Charmandari E. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations. Clin Endocrinol 2015;82:557–61.10.1111/cen.12653Suche in Google Scholar PubMed
11. Hindmarsh PC. The child with difficult to control congenital adrenal hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy. Clin Endocrinol 2014;81:15–8.10.1111/cen.12453Suche in Google Scholar
12. Frisch H, Parth K, Schober E, Swoboda W. Circadian patterns of plasma cortisol, 17- Hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia. Arch Dis Child 1981;56:208–13.10.1136/adc.56.3.208Suche in Google Scholar
13. Shimon I, Kaiserman I, Sack J. Home monitoring of 17a-hydroxyprogesterone levels by filter paper blood spots in patients with 21 hydroxylase deficiency. Horm Res 1995;44:247–52.10.1159/000184636Suche in Google Scholar
14. Bode HH, Rivkees SA, Cowley DM, Pardy K, Johnsons S. Home monitoring of 17-hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples. J Paediatr 1999;134:185–9.10.1016/S0022-3476(99)70413-0Suche in Google Scholar
15. Wieacker I, Peter M, Borucki K, Empting S, Roehl FW, et al. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples. J Pediatr Endocr Met 2015;28:867–71.10.1515/jpem-2014-0303Suche in Google Scholar PubMed
16. Sarafoglou K, Himes JH, Lacey JM, Netzel BC, Singh RJ, et al. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. Horm Res Paediatri 2011;75:19–25.10.1159/000315910Suche in Google Scholar PubMed PubMed Central
©2017 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Editorial
- Disorders of sex development
- Original Articles
- Fertility and sexual function: a gap in training in pediatric endocrinology
- Disorders of sex development in children in KwaZulu-Natal Durban South Africa: 20-year experience in a tertiary centre
- Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development
- Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
- Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, α-amylase inhibition, and retardation of glucose absorption
- Risk factors that affect metabolic health status in obese children
- Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep
- Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
- Food exchange estimation by children with type 1 diabetes at summer camp
- Usefulness of non-fasting lipid parameters in children
- Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia
- Clinical and molecular characterization of Beckwith-Wiedemann syndrome in a Chinese population
- An analysis of the sequence of the BAD gene among patients with maturity-onset diabetes of the young (MODY)
- Case Reports
- Hypogonadotropic hypogonadism in a female patient with congenital arhinia
- Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction
- Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2
- Three cases of Japanese acromicric/geleophysic dysplasia with FBN1 mutations: a comparison of clinical and radiological features
Artikel in diesem Heft
- Frontmatter
- Editorial
- Disorders of sex development
- Original Articles
- Fertility and sexual function: a gap in training in pediatric endocrinology
- Disorders of sex development in children in KwaZulu-Natal Durban South Africa: 20-year experience in a tertiary centre
- Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development
- Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
- Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, α-amylase inhibition, and retardation of glucose absorption
- Risk factors that affect metabolic health status in obese children
- Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep
- Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
- Food exchange estimation by children with type 1 diabetes at summer camp
- Usefulness of non-fasting lipid parameters in children
- Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia
- Clinical and molecular characterization of Beckwith-Wiedemann syndrome in a Chinese population
- An analysis of the sequence of the BAD gene among patients with maturity-onset diabetes of the young (MODY)
- Case Reports
- Hypogonadotropic hypogonadism in a female patient with congenital arhinia
- Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction
- Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2
- Three cases of Japanese acromicric/geleophysic dysplasia with FBN1 mutations: a comparison of clinical and radiological features
